🔎 Trials Near Me

Gara Jalqabaatti › Dhukkubbee Onkoloo Interstishiyali › California › Los Angeles

Qorannoo klinikaalii Dhukkubbee Onkoloo Interstishiyali Los Angeles, CA keessatti

Qorannoo 14 Dhukkubbee Onkoloo Interstishiyali f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

Namoota walitti qabaa jiraSadarkaa 3
  • University of Southern California, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT07540988

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Namoota walitti qabaa jiraSadarkaa 3
  • University of California Los Angeles, Los Angeles
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07201922

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Namoota walitti qabaa jiraSadarkaa 3
  • USA010, Los Angeles
  • USA023, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ful-2026 · NCT07179380

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT06572384

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Namoota walitti qabaa jiraSadarkaa 2/3
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
  • GSK Investigational Site, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 08-Ful-2026 · NCT05878717

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Namoota walitti qabaa jiraSadarkaa 2
  • University of Southern California, Los Angeles
  • Cedars Sinai Medical Center, Los Angeles
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT06968845

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

Namoota walitti qabaa jiraSadarkaa 3
  • David Geffen School of Medicine at UCLA, Los Angeles
Umuriin 18 hanga 80 · Saalaa hunda · Haaromfame 02-Ful-2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Namoota walitti qabaa jiraQorannoo ilaalaa
  • Cedars-Sinai Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06388421

Platform Clinical Study for Conquering Scleroderma

Namoota walitti qabaa jiraSadarkaa 2
  • Keck School of Medicine at USC Medical Center, Los Angeles
  • Cedars-Sinai Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT06195072

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of California - Los Angeles, Los Angeles
  • University of Southern California, Los Angeles
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT01915511

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Namoota walitti qabaa jiraSadarkaa 3
  • Peter Morton Medical Building, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Ado-2026 · NCT05943535

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Namoota walitti qabaa jiraSadarkaa 2
  • Keck School of Medicine of USC, Los Angeles
Umuriin 40 fi ol · Saalaa hunda · Haaromfame 12-Sad-2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Namoota walitti qabaa jiraSadarkaa 2
  • aTyr Investigative Site, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Cam-2025 · NCT05892614

Qorannoo Dhukkubbee Onkoloo Interstishiyali magaalota biroo keessatti

Qorannoo biroo Los Angeles keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.